Join
Live feed
·
PRReleasevia Quantisnow
Haemonetics Corporation logo
Orchestra BioMed Holdings Inc. logo

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HAE (Haemonetics Corporation), OBIO (Orchestra BioMed Holdings Inc.) and more on Quantisnow.